H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 10 650 KRW 0.28% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
HLB Life Science Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 577.83 KRW. Compared to the current market price of 10 650 KRW, HLB Life Science Co Ltd is Overvalued by 76%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 577.83 KRW
Overvaluation 76%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
HLB Life Science Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for HLB Life Science Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about HLB Life Science Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

10 650 KRW
+0.28%
+0.28%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

HLB Life Science Co Ltd
KR
Health Care
Market Cap
1.3T KRW
IPO
Nov 25, 2008
Employees
-
Korea
Market Cap
1.3T KRW
Industry
Health Care
IPO
Nov 25, 2008
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about HLB Life Science Co Ltd

Provide an overview of the primary business activities
of HLB Life Science Co Ltd.

What unique competitive advantages
does HLB Life Science Co Ltd hold over its rivals?

What risks and challenges
does HLB Life Science Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HLB Life Science Co Ltd.

Provide P/S
for HLB Life Science Co Ltd.

Provide P/E
for HLB Life Science Co Ltd.

Provide P/OCF
for HLB Life Science Co Ltd.

Provide P/FCFE
for HLB Life Science Co Ltd.

Provide P/B
for HLB Life Science Co Ltd.

Provide EV/S
for HLB Life Science Co Ltd.

Provide EV/GP
for HLB Life Science Co Ltd.

Provide EV/EBITDA
for HLB Life Science Co Ltd.

Provide EV/EBIT
for HLB Life Science Co Ltd.

Provide EV/OCF
for HLB Life Science Co Ltd.

Provide EV/FCFF
for HLB Life Science Co Ltd.

Provide EV/IC
for HLB Life Science Co Ltd.

Compare the intrinsic valuations
of HLB Life Science Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HLB Life Science Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of HLB Life Science Co Ltd compared to its peers.

Compare the P/E ratios
of HLB Life Science Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing HLB Life Science Co Ltd with its peers.

Analyze the financial leverage
of HLB Life Science Co Ltd compared to its main competitors.

Show all profitability ratios
for HLB Life Science Co Ltd.

Provide ROE
for HLB Life Science Co Ltd.

Provide ROA
for HLB Life Science Co Ltd.

Provide ROIC
for HLB Life Science Co Ltd.

Provide ROCE
for HLB Life Science Co Ltd.

Provide Gross Margin
for HLB Life Science Co Ltd.

Provide Operating Margin
for HLB Life Science Co Ltd.

Provide Net Margin
for HLB Life Science Co Ltd.

Provide FCF Margin
for HLB Life Science Co Ltd.

Show all solvency ratios
for HLB Life Science Co Ltd.

Provide D/E Ratio
for HLB Life Science Co Ltd.

Provide D/A Ratio
for HLB Life Science Co Ltd.

Provide Interest Coverage Ratio
for HLB Life Science Co Ltd.

Provide Altman Z-Score Ratio
for HLB Life Science Co Ltd.

Provide Quick Ratio
for HLB Life Science Co Ltd.

Provide Current Ratio
for HLB Life Science Co Ltd.

Provide Cash Ratio
for HLB Life Science Co Ltd.

What is the historical Revenue growth
over the last 5 years for HLB Life Science Co Ltd?

What is the historical Net Income growth
over the last 5 years for HLB Life Science Co Ltd?

What is the current Free Cash Flow
of HLB Life Science Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for HLB Life Science Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HLB Life Science Co Ltd

Current Assets 184.7B
Cash & Short-Term Investments 113B
Receivables 15.8B
Other Current Assets 55.9B
Non-Current Assets 427.9B
Long-Term Investments 287.4B
PP&E 87.8B
Intangibles 52.3B
Other Non-Current Assets 467m
Current Liabilities 100.8B
Accounts Payable 5.9B
Short-Term Debt 9.3B
Other Current Liabilities 85.5B
Non-Current Liabilities 78.8B
Long-Term Debt 73.9B
Other Non-Current Liabilities 4.9B
Efficiency

Earnings Waterfall
HLB Life Science Co Ltd

Revenue
97.1B KRW
Cost of Revenue
-99.9B KRW
Gross Profit
-2.8B KRW
Operating Expenses
-23.8B KRW
Operating Income
-26.6B KRW
Other Expenses
97.7B KRW
Net Income
71B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

HLB Life Science Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive 3-Years Revenue Growth
Positive ROE
ROIC is Increasing
31/100
Profitability
Score

HLB Life Science Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

HLB Life Science Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

HLB Life Science Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
HLB Life Science Co Ltd

There are no price targets for HLB Life Science Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

HLB Life Science Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for HLB Life Science Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one HLB Life Science Co Ltd stock?

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 577.83 KRW.

Is HLB Life Science Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10 650 KRW, HLB Life Science Co Ltd is Overvalued by 76%.

Back to Top